Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

DOD Counterdrug Activities: Reported Costs Do Not Reflect Extent of DOD's Support

NSIAD-98-231 Published: Sep 23, 1998. Publicly Released: Sep 23, 1998.
Jump To:

Highlights

Pursuant to a congressional request, GAO reviewed the full extent of the Department of Defense's (DOD) drug interdiction and other counterdrug activities, for fiscal year (FY) 1994 through FY 1998, focusing on: (1) the total operating and support (O&S) costs that can be associated with counterdrug activities; (2) the share of the original procurement costs of those weapons systems most often used by the active component in counterdrug activities; and (3) the amount of assistance DOD provided under section 506(a)(2)(A)(i)(I) of the Foreign Assistance Act.

Full Report

Full Report (15 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Public Inquiries

Contact Us

Topics

Justice and Law Enforcement
Cost accountingDrug traffickingHelicoptersInternational cooperationLaw enforcementMilitary aircraftMilitary budgetsMilitary operationsMilitary vesselsSmuggling